EconomyPfizer and Moderna have raised the price of their...

Pfizer and Moderna have raised the price of their vaccine for the EU, reveals the Financial Times

-

Business is business. According to the British economic newspaper the Financial Times, pharmaceutical companies Pfizer and Moderna have raised the price of their coronavirus vaccine as part of a deal with the European Union.

The Pfizer vaccine goes from 15.5 euros to 19.5 euros and that of Moderna from 19 euros to 21.5 euros according to the daily which consulted the contract. The rise comes as concern over the delta variant outbreak mounts and studies have shown that Moderna and Pfizer / BioNTech’s vaccines should remain effective against this variant.

Confidential contracts

Asked by AFP, the European Commission refused to comment on the confidentiality of contracts. Contacted in turn by AFP Pfizer and Moderna did not immediately react on Sunday.

The commission has always refused to communicate the price of the vaccines ordered. In December, a Belgian minister posted on Twitter – before erasing it – a table giving details of the amounts promised by her government to manufacturers for each of the six vaccines ordered, with the unit price in the EU: from 1.78 euros for the vaccine of the Swedish-British group AstraZeneca, to 18 US dollars (or 14.70 euros) for that of the American Moderna.

1.8 billion doses of Pfizer purchased

In May, the EU signed a new contract to buy up to 1.8 billion doses of vaccine from BioNTech-Pfizer, available until 2023, without revealing the price. In early July, European Commission President Ursula von der Leyen announced that the European Union had reached its goal of having enough doses in July to vaccinate 70% of its adult population (336 million people).

The EU’s joint vaccine purchasing program provided 330 million doses of the BioNTech-Pfizer vaccine, 100 million of AstraZeneca, 50 million of Moderna and 20 million of Johnson & Johnson. At the end of July, the Pfizer laboratory planned to sell this year for 33.5 billion dollars (28.23 billion euros) of vaccines against the Covid-19, that is to say much more than the 26 billion dollars (21.91 billion euros) on which the group had counted two months earlier. Moderna, in May, counted on annual sales of 19.5 billion dollars (16.43 billion euros).

Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Must read

You might also likeRELATED
Recommended to you